Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Werewolf Therapeutics, Inc.”

10 pharma patents match "Werewolf Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 10
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 10 pharmaceutical patents matching "Werewolf Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

10 results for “Werewolf Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12275769

    Activatable interleukin 12 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  2. US 12076371

    Activatable cytokine polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  3. US 12036266

    Activatable cytokine polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  4. US 11981716

    Activatable interleukin-2 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  5. US 11739132

    Separation moieties and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  6. US 11535658

    Activatable interleukin-2 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  7. US 11453710

    Activatable interleukin 12 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  8. US 11352403

    Activatable interleukin-2 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  9. US 10696723

    Activatable interleukin 12 polypeptides

    Werewolf Therapeutics, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted
  10. US 10696724

    Activatable interleukin-2 polypeptides

    Werewolf Therapeutics, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted